Calidi Biotherapeutics Files 8-K
Ticker: CLDWW · Form: 8-K · Filed: Aug 22, 2024 · CIK: 1855485
| Field | Detail |
|---|---|
| Company | Calidi Biotherapeutics, Inc. (CLDWW) |
| Form Type | 8-K |
| Filed Date | Aug 22, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, regulatory
Related Tickers: CLDI
TL;DR
Calidi Biotherapeutics filed a standard 8-K, no major news.
AI Summary
Calidi Biotherapeutics, Inc. filed an 8-K on August 22, 2024, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or material events beyond the standard reporting requirements.
Why It Matters
This filing indicates routine corporate reporting and does not disclose new material information that would immediately impact investors.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report and does not contain any new material information or significant financial disclosures.
Key Players & Entities
- Calidi Biotherapeutics, Inc. (company) — Registrant
- August 22, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-40789 (identifier) — Commission File Number
- 86-2967193 (identifier) — I.R.S. Employer Identification No.
- 4475 Executive Drive, Suite 200, San Diego, CA 92121 (address) — Business Address
- First Light Acquisition Group, Inc. (company) — Former Company Name
- 20210406 (date) — Date of Name Change
FAQ
What is the primary purpose of this Form 8-K filing?
The primary purpose of this Form 8-K filing is to report a Regulation FD Disclosure and to provide Financial Statements and Exhibits.
What is the exact name of the registrant as specified in its charter?
The exact name of the registrant is Calidi Biotherapeutics, Inc.
In which state is Calidi Biotherapeutics, Inc. incorporated?
Calidi Biotherapeutics, Inc. is incorporated in Delaware.
What is the Commission File Number for Calidi Biotherapeutics, Inc.?
The Commission File Number for Calidi Biotherapeutics, Inc. is 001-40789.
What was the former name of Calidi Biotherapeutics, Inc.?
The former name of Calidi Biotherapeutics, Inc. was First Light Acquisition Group, Inc.
Filing Stats: 566 words · 2 min read · ~2 pages · Grade level 11.2 · Accepted 2024-08-22 17:16:09
Key Financial Figures
- $0.0001 — ch Registered Common stock, par value $0.0001 per share CLDI NYSE American LLC
Filing Documents
- form8-k.htm (8-K) — 43KB
- ex99-1.htm (EX-99.1) — 18KB
- ex99-1_001.jpg (GRAPHIC) — 1222KB
- ex99-1_002.jpg (GRAPHIC) — 1813KB
- ex99-1_003.jpg (GRAPHIC) — 936KB
- ex99-1_004.jpg (GRAPHIC) — 909KB
- ex99-1_005.jpg (GRAPHIC) — 1208KB
- ex99-1_006.jpg (GRAPHIC) — 1150KB
- ex99-1_007.jpg (GRAPHIC) — 1097KB
- ex99-1_008.jpg (GRAPHIC) — 1155KB
- ex99-1_009.jpg (GRAPHIC) — 1080KB
- ex99-1_010.jpg (GRAPHIC) — 1119KB
- ex99-1_011.jpg (GRAPHIC) — 1062KB
- ex99-1_012.jpg (GRAPHIC) — 984KB
- ex99-1_013.jpg (GRAPHIC) — 1181KB
- ex99-1_014.jpg (GRAPHIC) — 1157KB
- ex99-1_015.jpg (GRAPHIC) — 983KB
- ex99-1_016.jpg (GRAPHIC) — 1302KB
- ex99-1_017.jpg (GRAPHIC) — 1128KB
- ex99-1_018.jpg (GRAPHIC) — 1514KB
- ex99-1_019.jpg (GRAPHIC) — 1183KB
- ex99-1_020.jpg (GRAPHIC) — 879KB
- ex99-1_021.jpg (GRAPHIC) — 1046KB
- ex99-1_022.jpg (GRAPHIC) — 931KB
- ex99-1_023.jpg (GRAPHIC) — 1117KB
- 0001493152-24-033579.txt ( ) — 36262KB
- cldi-20240822.xsd (EX-101.SCH) — 4KB
- cldi-20240822_def.xml (EX-101.DEF) — 26KB
- cldi-20240822_lab.xml (EX-101.LAB) — 36KB
- cldi-20240822_pre.xml (EX-101.PRE) — 25KB
- form8-k_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CALIDI BIOTHERAPEUTICS, INC. Dated: August 22, 2024 By: /s/ Andrew Jackson Name: Andrew Jackson Title: Chief Financial Officer